文献速递妇科产科

卵巢性索间质细胞肿瘤与性激素敏感癌症风险

Ovarian sex cord-stromal cell tumors and the risk of sex hormone-sensitive cancers.
PubMed 文献 · Am J Obstet Gynecol · 2025-01-21

这项巢式队列研究基于丹麦病理登记库纳入1387例卵巢性索间质细胞肿瘤女性并按1:10匹配对照,发现全部性索间质细胞肿瘤合并分析时同步子宫内膜癌风险升高(HR 3.3,95%CI 2.7-4.1),成年型颗粒细胞瘤尤为明显(HR 10.7,95%CI 5.7-20.1),卵泡膜瘤患者乳腺癌风险轻度升高(HR 1.2,95%CI 1.0-1.4)。

要点

  • 全部性索间质细胞肿瘤合并分析时同步子宫内膜癌风险升高,HR 3.3(95%CI 2.7-4.1)。
  • 成年型颗粒细胞瘤同步子宫内膜癌HR 10.7(95%CI 5.7-20.1),风险显著升高。
  • 肿瘤手术切除2个月后评估的子宫内膜癌风险未见升高。

核心结论

  • 性索间质细胞肿瘤女性同步子宫内膜癌风险升高,良性性索间质细胞肿瘤女性同步卵巢癌风险升高。
  • 卵泡膜瘤女性观察到乳腺癌风险轻度升高,成年型颗粒细胞瘤女性乳腺癌风险未升高。
  • 推荐对确诊激素分泌性性索间质细胞肿瘤且合并子宫内膜癌其他危险因素(异常子宫出血和/或子宫内膜厚度异常)的女性行子宫内膜活检以评估是否存在癌症。

研究设计与样本

  • 巢式队列研究,利用丹麦病理登记库的系统化医学命名法编码建立性索间质细胞肿瘤女性队列。
  • 性索间质细胞肿瘤诊断需由三级转诊中心确立或至少2名病理学家确认方视为有效。
  • 从国家登记库按出生年份1:10匹配选取对照组。
  • 1516例编码为性索间质细胞肿瘤的肿瘤中,经病理病历复核后1387例符合纳入标准。
  • 采用多变量Cox比例风险模型计算癌症发生率的风险比,并分别建立早期和延迟模型以捕捉随时间变化的癌症发生率。

主要发现

  • 多数为良性肿瘤,主要为卵泡膜瘤或纤维卵泡膜瘤(66%),26%为成年型颗粒细胞瘤。
  • 卵泡膜瘤患者乳腺癌风险升高,HR 1.2(95%CI 1.0-1.4)。
  • 全部性索间质细胞肿瘤合并分析时同步子宫内膜癌风险升高,HR 3.3(95%CI 2.7-4.1)。
  • 亚组分析中恶性和良性性索间质细胞肿瘤同步子宫内膜癌风险比均显著升高,成年型颗粒细胞瘤HR 10.7(95%CI 5.7-20.1)。
  • 在性索间质细胞肿瘤手术切除2个月后评估子宫内膜癌发生率的模型中,未发现风险升高。

关键数值与推荐

  • 支持细胞瘤与乳腺癌发生率升高相关,标化发病比18.9(95%CI 2.7-134)。
  • 支持细胞瘤与同步子宫内膜癌发生率升高相关,标化发病比41.4(95%CI 10.4-166)。
  • 间质细胞瘤与同步子宫内膜癌发生率升高相关,标化发病比44.9(95%CI 18.7-108)。

临床怎么用

  • 作者认为,确诊激素分泌性性索间质细胞肿瘤且合并子宫内膜癌其他危险因素(异常子宫出血和/或子宫内膜厚度异常)的女性应行子宫内膜活检以评估是否存在癌症。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Sex cord-stromal cell tumors are rare ovarian tumors. Some sex cord-stromal cell tumors secrete hormones that originate from the ovarian sex or stromal cells. Previous studies have indicated an increased risk for breast and endometrial cancers. However, these studies focused only on the sex cord-stromal cell tumor-subtype of adult granulosa cell tumors, and the estimates stemmed from selected cohorts and lacked a well-described cohort, making it difficult to adjust for possible confounders. OBJECTIVE: We examined the incidence of other primary hormone-sensitive cancers and compared their risk with that in a matched cohort of women without sex cord-stromal cell tumors. STUDY DESIGN: This nested cohort study evaluated women diagnosed with sex cord-stromal cell tumors. We established a cohort of women diagnosed with sex cord-stromal cell tumors using Systematized Medical Nomenclature for Medicine codes from the Danish Pathology Register. Sex cord-stromal cell tumors diagnoses were considered valid if the primary diagnosis was established at a tertiary referral center or confirmed by at least 2 pathologists. A 1:10 matched control group matched by birth year was selected from national registries. Variables for the follow-up of cases and controls were drawn from national registries and included assessment of the rates of breast, ovarian, and endometrial cancer, hormone use, Charlson Comorbidity Index, and sociodemographics. Hazard ratios for cancer rates were calculated using multivariate Cox proportional hazards models with sex cord-stromal cell tumor exposure estimated in early and delayed models to capture cancer rates over time. The standardized incidence ratios for very rare sex cord-stromal cell tumors were determined using a log-linear Poisson model. RESULTS: Among the 1516 tumors with Systematized Medical Nomenclature for Medicine codes for sex cord-stromal cell tumors, 1387 met the inclusion criteria after pathologic chart review. The majority had benign tumors, primarily thecoma or fibrothecomas (66%), and 26% had adult granulosa cell tumors. Increased rates of breast cancer were found among patients with thecomas (hazard ratio, 1.2; 95% confidence interval, 1.0-1.4). In the analysis of all sex cord-stromal cell tumors combined, an increased rate of synchronous endometrial cancer was found (hazard ratio, 3.3; 95% confidence interval, 2.7-4.1). In the subgroup analysis, malignant and benign sex cord-stromal cell tumors showed significantly higher hazard ratios for synchronous endometrial cancer, notably adult granulosa cell tumors (hazard ratio, 10.7; 95% confidence interval, 5.7-20.1). In the model that assessed the rates of endometrial cancer 2 months after surgical removal of the sex cord-stromal cell tumor, no increased rates were found. Sertoli cell tumors were associated with an increased incidence of breast cancer (standardized incidence ratio, 18.9; 95% confidence interval, 2.7-134). Both Sertoli and Leydig cell tumors were associated with a higher incidence of synchronous endometrial cancer with standardized incidence ratios of 41.4 (95% confidence interval, 10.4-166) and 44.9 (95% confidence interval, 18.7-108), respectively. CONCLUSION: Women with sex cord-stromal cell tumors have an increased rate of synchronous endometrial cancer, and women with benign sex cord-stromal cell tumors have an increased rate of synchronous ovarian cancer. A marginally increased rate of breast cancer has been observed in women with thecomas. There was no increase in the rate of breast cancer among women with adult granulosa cell tumors. It is recommended that women diagnosed with hormone-secreting sex cord-stromal cell tumors and additional risk factors for endometrial cancer (abnormal uterine bleeding and/or abnormal endometrial thickness) should undergo an endometrial biopsy to assess for the presence of cancer.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Karstensen S, Jochumsen K, Høgdall C, et al. Ovarian sex cord-stromal cell tumors and the risk of sex hormone-sensitive cancers. Am J Obstet Gynecol. 2025. PMID: 39848393. doi:10.1016/j.ajog.2025.01.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。